Linked Life Data

12712239

Source:http://linkedlifedata.com/resource/pubmed/id/12712239

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-6-11
pubmed:abstractText
Based on the results of the PROWESS trial the European Agency for the Evaluation of Medicinal Products has recently approved drotrecogin alfa (activated) for treatment of adult patients with severe sepsis and multiple-organ failure. We report study's data on efficacy and safety in patients with multiple-organ dysfunction.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0342-4642
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
894-903
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12712239-APACHE, pubmed-meshheading:12712239-Aged, pubmed-meshheading:12712239-Anti-Infective Agents, pubmed-meshheading:12712239-Biological Markers, pubmed-meshheading:12712239-Double-Blind Method, pubmed-meshheading:12712239-Europe, pubmed-meshheading:12712239-Female, pubmed-meshheading:12712239-Fibrinolytic Agents, pubmed-meshheading:12712239-Hemorrhage, pubmed-meshheading:12712239-Humans, pubmed-meshheading:12712239-Male, pubmed-meshheading:12712239-Middle Aged, pubmed-meshheading:12712239-Multiple Organ Failure, pubmed-meshheading:12712239-Proportional Hazards Models, pubmed-meshheading:12712239-Protein C, pubmed-meshheading:12712239-Recombinant Proteins, pubmed-meshheading:12712239-Risk Factors, pubmed-meshheading:12712239-Sepsis, pubmed-meshheading:12712239-Survival Analysis, pubmed-meshheading:12712239-Thrombosis, pubmed-meshheading:12712239-Treatment Outcome, pubmed-meshheading:12712239-United States
pubmed:year
2003
pubmed:articleTitle
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.
pubmed:affiliation
Department of Intensive Care, Cochin Hospital AP-HP, Cochin Institute, Cochin Port-Royal Medical School, Paris V University, 27 rue due Faubourg Saint Jacques, 75679, Paris cedex 14, France. jean-francois.dhainaut@cch.ap-hop-paris.fr
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study